The Pathophysiological Relevance of Monocyte-platelet Interactions in Inflammatory Disease

Journal of Experimental and Clinical Medicine

Volumn 2, Issue 6, 2010, Pages 262-268

  Stephen, Jillian ^a   Dransfield, Ian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Inflammation; Monocyte; Platelet; PSGL 1

Indexed keywords

BETA2 INTEGRIN; CD40 ANTIGEN; CD40 LIGAND; CHEMOKINE; CYTOKINE; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; SCLEROPROTEIN;

ATHEROSCLEROSIS; CELL ADHESION; CELL INTERACTION; COMPLEX FORMATION; DIABETES MELLITUS; DISEASE COURSE; HUMAN; MOLECULAR MECHANICS; MONOCYTE; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; UPREGULATION;

EID: 78650183955     PISSN: 18783317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jecm.2010.08.002     Document Type: Review

References (77)

1. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007, 7:678-689.
2. Kansas G.S. Selectins and their ligands: current concepts and controversies. Blood 1996, 88:3259-3287.
3. McEver R.P., Cummings R.D. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 1997, 100:S97-103.
4. Bonfanti R., Furie B.C., Furie B., Wagner D.D. PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 1989, 73:1109-1112.
5. Stenberg P.E., McEver R.P., Shuman M.A., Jacques Y.V., Bainton D.F. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985, 101:880-886.
6. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11-25.
7. McDowall A., Svensson L., Stanley P., Patzak I., Chakravarty P., Howarth K., Sabnis S., et al. Two mutations in the KINDLIN3 gene of a new leukocyte adhesion deficiency-III patient reveal distinct effects on leukocyte function in vitro. Blood 2010, 115:4834-4842.
8. Ghandour H., Cullere X., Alvarez A., Luscinskas F.W., Mayadas T.N. Essential role for Rap1 GTPase and its guanine exchange factor CalDAG-GEFI in LFA-1 but not VLA-4 integrin mediated human T-cell adhesion. Blood 2007, 110:3682-3690.
9. Lee H.S., Lim C.J., Puzon-McLaughlin W., Shattil S.J., Ginsberg M.H. RIAM activates integrins by linking talin to ras GTPase membrane-targeting sequences. J Biol Chem 2009, 284:5119-5127.
10. Carlow D.A., Corbel S.Y., Williams M.J., Ziltener H.J. IL-2, -4, and -15 differentially regulate O-glycan branching and P-selectin ligand formation in activated CD8 T cells. J Immunol 2001, 167:6841-6848.
11. Rinder H.M., Bonan J.L., Rinder C.S., Ault K.A., Smith B.R. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991, 78:1730-1737.
12. Ahn K.C., Jun A.J., Pawar P., Jadhav S., Napier S., McCarty O.J., Konstantopoulos K. Preferential binding of platelets to monocytes over neutrophils under flow. Biochem Biophys Res Commun 2005, 329:345-355.
13. Bournazos S., Rennie J., Hart S.P., Fox K.A., Dransfield I. Monocyte functional responsiveness after PSGL-1-mediated platelet adhesion is dependent on platelet activation status. Arterioscler Thromb Vasc Biol 2008, 28:1491-1498.
14. Passlick B., Flieger D., Ziegler-Heitbrock H.W. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989, 74:2527-2534.
15. Ziegler-Heitbrock H.W., Passlick B., Flieger D. The monoclonal antimonocyte antibody My4 stains B lymphocytes and two distinct monocyte subsets in human peripheral blood. Hybridoma 1988, 7:521-527.
16. Ancuta P., Rao R., Moses A., Mehle A., Shaw S.K., Luscinskas F.W., Gabuzda D. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med 2003, 197:1701-1707.
17. Belge K.U., Dayyani F., Horelt A., Siedlar M., Frankenberger M., Frankenberger B., Espevik T., et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 2002, 168:3536-3542.
18. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
19. Ziegler-Heitbrock H.W., Fingerle G., Strobel M., Schraut W., Stelter F., Schutt C., Passlick B., et al. The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol 1993, 23:2053-2058.
20. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007, 81:584-592.
21. Boudjeltia K.Z., Brohee D., Piro P., Nuyens V., Ducobu J., Kherkofs M., Van Antwerpen P., et al. Monocyte-platelet complexes on CD14/CD16 monocyte subsets: relationship with ApoA-I levels. A preliminary study. Cardiovasc Pathol 2008, 17:285-288.
22. Huo Y., Schober A., Forlow S.B., Smith D.F., Hyman M.C., Jung S., Littman D.R., et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003, 9:61-67.
23. Sarma J., Laan C.A., Alam S., Jha A., Fox K.A., Dransfield I. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 2002, 105:2166-2171.
24. Harding S.A., Sommerfield A.J., Sarma J., Twomey P.J., Newby D.E., Frier B.M., Fox K.A. Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis 2004, 176:321-325.
25. Joseph J.E., Harrison P., Mackie I.J., Isenberg D.A., Machin S.J. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 2001, 115:451-459.
26. Michelson A.D., Barnard M.R., Krueger L.A., Valeri C.R., Furman M.I. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001, 104:1533-1537.
27. Weyrich A.S., McIntyre T.M., McEver R.P., Prescott S.M., Zimmerman G.A. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest 1995, 95:2297-2303.
28. Weyrich A.S., Elstad M.R., McEver R.P., McIntyre T.M., Moore K.L., Morrissey J.H., Prescott S.M., et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996, 97:1525-1534.
29. Neumann F.J., Marx N., Gawaz M., Brand K., Ott I., Rokitta C., Sticherling C., et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 1997, 95:2387-2394.
30. Galt S.W., Lindemann S., Medd D., Allen L.L., Kraiss L.W., Harris E.S., Prescott S.M., et al. Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets. Circ Res 2001, 89:509-516.
31. Tsuji T., Nagata K., Koike J., Todoroki N., Irimura T. Induction of superoxide anion production from monocytes an neutrophils by activated platelets through the P-selectin-sialyl Lewis X interaction. J Leukoc Biol 1994, 56:583-587.
32. Bournazos S., Rennie J., Hart S.P., Dransfield I. Choice of anticoagulant critically affects measurement of circulating platelet-leukocyte complexes. Arterioscler Thromb Vasc Biol 2008, 28:e2-e3.
33. Fernandes L.S., Conde I.D., Wayne Smith C., Kansas G.S., Snapp K.R., Bennet N., Ballantyne C., et al. Platelet-monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with alphaIIbbeta3 and alphaMbeta2, in coronary stenting. Thromb Res 2003, 111:171-177.
34. Rinder H.M., Bonan J.L., Rinder C.S., Ault K.A., Smith B.R. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 1991, 78:1760-1769.
35. Larsen E., Palabrica T., Sajer S., Gilbert G.E., Wagner D.D., Furie B.C., Furie B. PADGEM-dependent adhesion of platelets to monocytes and neutrophils is mediated by a lineage-specific carbohydrate, LNF III (CD15). Cell 1990, 63:467-474.
36. da Costa Martins P.A., van Gils J.M., Mol A., Hordijk P.L., Zwaginga J.J. Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins. J Leukoc Biol 2006, 79:499-507.
37. Simon D.I., Chen Z., Xu H., Li C.Q., Dong J., McIntire L.V., Ballantyne C.M., et al. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000, 192:193-204.
38. Kuijper P.H., Gallardo Torres H.I., Houben L.A., Lammers J.W., Zwaginga J.J., Koenderman L. P-selectin and MAC-1 mediate monocyte rolling and adhesion to ECM-bound platelets under flow conditions. J Leukoc Biol 1998, 64:467-473.
39. Santoso S., Sachs U.J., Kroll H., Linder M., Ruf A., Preissner K.T., Chavakis T. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med 2002, 196:679-691.
40. Wright S.D., Weitz J.I., Huang A.J., Levin S.M., Silverstein S.C., Loike J.D. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc Natl Acad Sci U S A 1988, 85:7734-7738.
41. Altieri D.C., Morrissey J.H., Edgington T.S. Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade. Proc Natl Acad Sci U S A 1988, 85:7462-7466.
42. Weber C., Erl W., Weber K.S., Weber P.C. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. J Am Coll Cardiol 1997, 30:1212-1217.
43. Xie J., Li R., Kotovuori P., Vermot-Desroches C., Wijdenes J., Arnaout M.A., Nortamo P., et al. Intercellular adhesion molecule-2 (CD102) binds to the leukocyte integrin CD11b/CD18 through the A domain. J Immunol 1995, 155:3619-3628.
44. Wachtfogel Y.T., DeLa Cadena R.A., Kunapuli S.P., Rick L., Miller M., Schultze R.L., Altieri D.C., et al. High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). J Biol Chem 1994, 269:19307-19312.
45. Harding S.A., Sarma J., Josephs D.H., Cruden N.L., Din J.N., Twomey P.J., Fox K.A., et al. Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers. Circulation 2004, 109:1926-1929.
46. Schonbeck U., Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001, 58:4-43.
47. Mach F., Schonbeck U., Bonnefoy J.Y., Pober J.S., Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 1997, 96:396-399.
48. Henn V., Slupsky J.R., Grafe M., Anagnostopoulos I., Forster R., Muller-Berghaus G., Kroczek R.A. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998, 391:591-594.
49. Lindmark E., Tenno T., Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 2000, 20:2322-2328.
50. Seizer P., Borst O., Langer H.F., Bultmann A., Munch G., Herouy Y., Stellos K., et al. EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction. Thromb Haemost 2009, 101:682-686.
51. Biswas C., Zhang Y., DeCastro R., Guo H., Nakamura T., Kataoka H., Nabeshima K. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995, 55:434-439.
52. Bouchon A., Dietrich J., Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000, 164:4991-4995.
53. Haselmayer P., Grosse-Hovest L., von Landenberg P., Schild H., Radsak M.P. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 2007, 110:1029-1035.
54. Serrador J.M., Alonso-Lebrero J.L., del Pozo M.A., Furthmayr H., Schwartz-Albiez R., Calvo J., Lozano F., et al. Moesin interacts with the cytoplasmic region of intercellular adhesion molecule-3 and is redistributed to the uropod of T lymphocytes during cell polarization. J Cell Biol 1997, 138:1409-1423.
55. Serrador J.M., Urzainqui A., Alonso-Lebrero J.L., Cabrero J.R., Montoya M.C., Vicente-Manzanares M., Yanez-Mo M., et al. A juxta-membrane amino acid sequence of P-selectin glycoprotein ligand-1 is involved in moesin binding and ezrin/radixin/moesin-directed targeting at the trailing edge of migrating lymphocytes. Eur J Immunol 2002, 32:1560-1566.
56. Evangelista V., Pamuklar Z., Piccoli A., Manarini S., Dell'elba G., Pecce R., Martelli N., et al. Src family kinases mediate neutrophil adhesion to adherent platelets. Blood 2007, 109:2461-2469.
57. Urzainqui A., Serrador J.M., Viedma F., Yanez-Mo M., Rodriguez A., Corbi A.L., Alonso-Lebrero J.L., et al. ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1. Immunity 2002, 17:401-412.
58. Carlow D.A., Gossens K., Naus S., Veerman K.M., Seo W., Ziltener H.J. PSGL-1 function in immunity and steady state homeostasis. Immunol Rev 2009, 230:75-96.
59. Alonso-Lebrero J.L., Serrador J.M., Dominguez-Jimenez C., Barreiro O., Luque A., del Pozo M.A., Snapp K., et al. Polarization and interaction of adhesion molecules P-selectin glycoprotein ligand 1 and intercellular adhesion molecule 3 with moesin and ezrin in myeloid cells. Blood 2000, 95:2413-2419.
60. Bruehl R.E., Moore K.L., Lorant D.E., Borregaard N., Zimmerman G.A., McEver R.P., Bainton D.F. Leukocyte activation induces surface redistribution of P-selectin glycoprotein ligand-1. J Leukoc Biol 1997, 61:489-499.
61. Lorant D.E., Zimmerman G.A., McIntyre T.M., Prescott S.M. Platelet-activating factor mediates procoagulant activity on the surface of endothelial cells by promoting leukocyte adhesion. Semin Cell Biol 1995, 6:295-303.
62. Snapp K.R., Heitzig C.E., Kansas G.S. Attachment of the PSGL-1 cytoplasmic domain to the actin cytoskeleton is essential for leukocyte rolling on P-selectin. Blood 2002, 99:4494-4502.
63. Dore M., Simon S.I., Hughes B.J., Entman M.L., Smith C.W. P-selectin- and CD18-mediated recruitment of canine neutrophils under conditions of shear stress. Vet Pathol 1995, 32:258-268.
64. Mocsai A., Ruland J., Tybulewicz V.L. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol 2010, 10:387-402.
65. Berton G., Mocsai A., Lowell C.A. Src and Syk kinases: key regulators of phagocytic cell activation. Trends Immunol 2005, 26:208-214.
66. Miner J.J., Xia L., Yago T., Kappelmayer J., Liu Z., Klopocki A.G., Shao B., et al. Separable requirements for cytoplasmic domain of PSGL-1 in leukocyte rolling and signaling under flow. Blood 2008, 112:2035-2045.
67. Suen P.W., Ilic D., Caveggion E., Berton G., Damsky C.H., Lowell C.A. Impaired integrin-mediated signal transduction, altered cytoskeletal structure and reduced motility in Hck/Fgr deficient macrophages. J Cell Sci 1999, 112(Pt 22):4067-4078.
68. Piccardoni P., Sideri R., Manarini S., Piccoli A., Martelli N., de Gaetano G., Cerletti C., et al. Platelet/polymorphonuclear leukocyte adhesion: a new role for SRC kinases in Mac-1 adhesive function triggered by P-selectin. Blood 2001, 98:108-116.
69. Totani L., Piccoli A., Manarini S., Federico L., Pecce R., Martelli N., Cerletti C., et al. Src-family kinases mediate an outside-in signal necessary for beta2 integrins to achieve full activation and sustain firm adhesion of polymorphonuclear leucocytes tethered on E-selectin. Biochem J 2006, 396:89-98.
70. Wang H.B., Wang J.T., Zhang L., Geng Z.H., Xu W.L., Xu T., Huo Y., et al. P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol 2007, 8:882-892.
71. Okkenhaug K., Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol 2003, 3:317-330.
72. Dixon D.A., Tolley N.D., Bemis-Standoli K., Martinez M.L., Weyrich A.S., Morrow J.D., Prescott S.M., et al. Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J Clin Invest 2006, 116:2727-2738.
73. Cipollone F., Fazia M.L. COX-2 and atherosclerosis. J Cardiovasc Pharmacol 2006, 47(Suppl 1):S26-S36.
74. Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994, 12:141-179.
75. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994, 10:405-455.
76. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994, 94:2493-2503.
77. Schmidt R., Bultmann A., Fischel S., Gillitzer A., Cullen P., Walch A., Jost P., et al. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes. Circ Res 2008, 102:302-309.